252 related articles for article (PubMed ID: 18925853)
21. Current state of adjuvant therapy in resected pancreatic adenocarcinoma.
Bergenfeldt M; Albertsson M
Acta Oncol; 2006; 45(2):124-35. PubMed ID: 16546857
[TBL] [Abstract][Full Text] [Related]
22. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
Abrams RA; Yeo CJ
Surg Oncol Clin N Am; 2004 Oct; 13(4):621-38, ix. PubMed ID: 15350938
[TBL] [Abstract][Full Text] [Related]
23. [Multimodality treatment of carcinoma of the pancreas].
Tsuchiya R; Yamamoto K; Miyamoto T; Yamaguchi T; Izawa K; Tsunoda T; Harada N
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):945-50. PubMed ID: 2730034
[TBL] [Abstract][Full Text] [Related]
24. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant treatments for resectable pancreatic cancer.
Ueno H; Kosuge T
J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
[TBL] [Abstract][Full Text] [Related]
26. Management of borderline resectable pancreatic adenocarcinoma.
Jia Y; Wang TJ; Allendorf J; Saif MW
JOP; 2012 Mar; 13(2):147-50. PubMed ID: 22406587
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten-year single institution experience.
Turrini O; Viret F; Moureau-Zabotto L; Guiramand J; Moutardier V; Lelong B; de Chaisemartin C; Giovannini M; Delpero JR
Oncology; 2009; 76(6):413-9. PubMed ID: 19407474
[TBL] [Abstract][Full Text] [Related]
28. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant strategies for resectable pancreatic cancer: have we made progress?
Russo S; Jain AK; Saif MW
JOP; 2012 Mar; 13(2):139-42. PubMed ID: 22406585
[TBL] [Abstract][Full Text] [Related]
30. Adenocarcinoma of the pancreas--past, present and future.
Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
Hepatogastroenterology; 2005; 52(64):1281-92. PubMed ID: 16001679
[TBL] [Abstract][Full Text] [Related]
31. Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy.
Evans DB; Erickson BA; Ritch P
Ann Surg Oncol; 2010 Nov; 17(11):2803-5. PubMed ID: 20737218
[No Abstract] [Full Text] [Related]
32. [Up-to-date diagnosis and treatment of advanced pancreatic cancer].
Stieler JM; Oettle H
Dtsch Med Wochenschr; 2005 Sep; 130(38):2146-8. PubMed ID: 16172956
[TBL] [Abstract][Full Text] [Related]
33. Controversies in the adjuvant treatment of pancreatic adenocarcinoma.
Saif MW
JOP; 2007 Sep; 8(5):545-52. PubMed ID: 17873458
[TBL] [Abstract][Full Text] [Related]
34. [Pancreatic carcinoma].
Böhmig M; Rosewicz S
Z Gastroenterol; 2004 Mar; 42(3):261-8. PubMed ID: 15022114
[TBL] [Abstract][Full Text] [Related]
35. [Concomitant chemoradiotherapy in tumors of the pancreas].
Soumarová R; Perková H; Seneklová Z; Karásek P
Cas Lek Cesk; 2003; 142 Suppl 1():29-31. PubMed ID: 12924047
[TBL] [Abstract][Full Text] [Related]
36. Advances in borderline resectable pancreatic adenocarcinoma.
Vadehra D; Salibi PN; McHaffie DR; Sulzer J; Iannitti DA; Hwang JJ
Clin Adv Hematol Oncol; 2020 May; 18(5):280-288. PubMed ID: 32628656
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and therapeutic approach to pancreatic adenocarcinoma.
Germanos S; Gourgiotis S; Stavrothanasopoulou A; Alepas P; Zampitis N; Panteli A
J Gastrointestin Liver Dis; 2006 Sep; 15(3):257-63. PubMed ID: 17013451
[TBL] [Abstract][Full Text] [Related]
38. [Present state of the multidisciplinary treatment of pancreatic carcinoma].
Hanyu F; Nakamura M
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1140-5. PubMed ID: 3932715
[TBL] [Abstract][Full Text] [Related]
39. The Multidisciplinary Approach to Localized Pancreatic Adenocarcinoma.
Parekh HD; Starr J; George TJ
Curr Treat Options Oncol; 2017 Nov; 18(12):73. PubMed ID: 29143898
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic adenocarcinoma: a review for primary care physicians.
Postier RG; Williams GR
J Okla State Med Assoc; 1993 Oct; 86(10):492-5. PubMed ID: 7504097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
